Wenbin Zhao

10PUBLICATIONS
18CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)NeonatologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 05, 2026
Designing T-cell Engagers: Trade-offs Between Activity and Safety.

|Apr 08, 2026
DJ-1 inhibition reshapes tumor microenvironment and potentiates immune checkpoint inhibitors.

Haiying Zhu, Yushen Lin, Li Jiang

|Apr 27, 2024
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy.

Yiming Li, Wenbin Zhao, Ying Shen

|Feb 23, 2024
Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control.

Li Lu, Mingqi Xie, Bo Yang

|Oct 26, 2021
Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2.

Yi-Sheng Sun, Jing-Jing Zhou, Han-Ping Zhu

|Sep 28, 2021
Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy.

Xuefei Bai, Wenhui Liu, Shijie Jin

Pageof 2

Frequent Collaborators

6 joint publications

Zhan Zhou

5 joint publications

Shuqing Chen

3 joint publications

Ji Cao

1 joint publications

Yi-Sheng Sun